Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary...

Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership

SILICON VALLEY, Calif., June 27, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth...

Fractal Appoints Leandro DalleMule as Chief Practice Officer, Financial Services & Insurance

"Leandro...

Sun Life Celebrates 18 Wins at the Bloomberg Businessweek Financial Institution Awards 2026

A...

AXA Wins 7 Accolades at Bloomberg Businessweek Financial Institutions Awards 2026

Retains Consecutive Insurance Company of the Year Award HONG KONG, June 26, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") is...

Hoymiles Presents Full-Scenario Energy Solutions and Expands Strategic Partnerships at Intersolar Europe 2026

MUNICH,...

MetaOptics Begins Shipment of Metalens Smartphone and AI Smart Glasses to European and Japanese Customers for Evaluation

SINGAPORE, June 26, 2026 /PRNewswire/ -- MetaOptics Ltd. (Catalist: 9MT) ("MetaOptics" or the "Company"), a leading-edge semiconductor optics company pioneering metalens technology, today announced...
1...109110111...4,262Page 110 of 4,262